|
- 340B Drug Pricing Program | HRSA
The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices
- 340B Eligibility | HRSA
Discover eligibility and registration details for HRSA's 340B Drug Pricing Program to help entities access discounted medications
- 340B Educational Resources | HRSA
Our website provides resources to help 340B Program stakeholders with navigating the 340B Program, including registration and implementation, requirements compliance, program integrity, and more:
- Program Requirements | HRSA
To purchase drugs at the 340B price, covered entities must continue to meet the requirements of the 340B Drug Pricing Program
- HRSA Announces Application Process for the 340B Rebate Model Pilot . . .
Today, the Health Resources and Services Administration (HRSA) announced the availability of a voluntary 340B Rebate Model Pilot Program for drugs on the CMS Medicare Drug Price Negotiation Selected Drug List for year 2026 from qualifying manufacturers meeting specific criteria
- 340B-Search Covered Entities
An official website of the United States government Here's how you know About 340B OPAIS Home Search Reports
- 340B Rebate Model Pilot Program | HRSA
The 340B Rebate Model Pilot Program consists of a selected group of drugs of manufacturers who have submitted plans meeting specific criteria that HRSA has approved
- 340B Office of Pharmacy Affairs Information System | HRSA
The 340B registration and pricing databases are known as the 340B Office of Pharmacy Affairs Information System (340B OPAIS) Authorized users of 340B OPAIS must have a user account with appropriate roles and permissions granted by HRSA
|
|
|